A key early innovator in that race is Everest Medicines Ltd. (1952.HK), China's leading biopharma company to integrate AI into mRNA cancer vaccine research. The company is advancing its AI ...

Development of a breakthrough vaccine researchers say could eradicate breast cancer wrapped up its phase one clinical trial ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Morningstar brands and products Company Portfolio ...

The HPV vaccine has demonstrated safety and provides protection ... likely to experience a missed HPV vaccination opportunity. Using AI to Prevent Cancers Caused by HPV Huntsman Cancer Institute is ...

which specializes in AI platforms for antigen discovery, has reported one-year interim data from a Phase II trial (NCT05309421) underway for its peptide-based personalized cancer vaccine candidate ...

Today, we talk about the FDA’s new artificial intelligence effort in the wake of mass layoffs, see AI darling Insitro cut staff, and more. Calling it a “historic first,” FDA chief Marty ...

Anixa Biosciences secured a six-month exclusive right to negotiate a deal for VERDI's cancer vaccines. VERDI’s AI-driven platform develops personalized and off-the-shelf peptide vaccines for ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

Research in mice shows that the vaccine has been successful in activating the immune system against alpha-lactalbumin and ...

Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer vaccine currently being evaluated as a treatment for advanced melanoma (skin cancer). The extension will ...